Does Wegovy cause heartburn — and what can you do about it?

The common belief that heartburn means the medicine isn't working

A lot of people starting Wegovy assume that digestive side effects like heartburn mean something has gone wrong, or that their dose is too high, or that the medicine simply isn't agreeing with them. That is understandable, but it is not quite right.

Heartburn during the early weeks of Wegovy is, in a very real sense, a sign the medicine is doing its job. Semaglutide activates GLP-1 receptors in the gut, which significantly slows gastric emptying — food sits in the stomach for longer, which is a large part of why appetite falls. The side-effect of that slower emptying is that stomach acid has more opportunity to splash back into the lower oesophagus, producing the familiar burning sensation behind the breastbone.

According to the NHS medicines page for semaglutide, indigestion and reflux are listed common side effects of Wegovy. They tend to cluster around dose increases, peaking in the first fortnight and gradually easing as the gut adapts. Heartburn appearing at week two does not mean you should stop, but it does mean you should tell your prescriber, because there are practical steps that genuinely reduce it.

The misconception worth correcting, then, is not that heartburn is rare. It is that heartburn is a warning sign to panic about. For the majority of people it is a temporary adjustment, not a reason to abandon treatment that may otherwise be working well.

Why the dose-escalation schedule matters for reflux

Wegovy is not started at its maintenance dose. The titration pathway moves from 0.25 mg up through several steps before reaching 2.4 mg, a process that typically takes around four to five months. The slow escalation exists precisely to allow the gut to adjust, and reflux is one of the symptoms the schedule is designed to blunt.

In practice, heartburn flares most predictably at each step up. If you increase to 1.0 mg on a Monday and find yourself uncomfortable by Wednesday evening, that pattern is consistent with what the clinical data show. The STEP 1 trial published in the New England Journal of Medicine (which established semaglutide 2.4 mg's efficacy across 68 weeks) recorded gastrointestinal events as the most common adverse effects, with nausea, reflux and indigestion concentrated in the dose-escalation period rather than during stable maintenance treatment.

One practical note: try not to schedule a dose increase on a day when you need to be fully on form. Some people find their first day or two at a new level manageable; others notice enough discomfort that a quieter week is worth planning for. That is not medical advice about timing (your prescriber sets the schedule) it is just the kind of real-world consideration that does not always make it into the leaflet.

If heartburn at a particular dose is making daily life difficult, speak to your prescriber before increasing further. Staying a little longer at a lower dose is a recognised option and is always preferable to stopping altogether.

What actually reduces heartburn on Wegovy

Lifestyle adjustments make a measurable difference here, and several are worth building into your routine from the first pen rather than waiting until symptoms appear.

Meal size is probably the single most effective lever. Because food is leaving the stomach more slowly, large meals dramatically increase the risk of reflux. Smaller portions, eaten more often, keep stomach pressure lower. High-fat foods slow gastric emptying further still (they compound the effect semaglutide is already producing) so reducing greasy or very rich food is especially useful during the early weeks.

Staying upright for at least an hour after eating helps gravity keep stomach contents where they belong. Many people taking Wegovy eat less at dinner; if that is the case for you, eating the last meal a bit earlier in the evening rather than just before bed is worth trying. Propping up the head of the bed by a few inches can also reduce overnight reflux.

Fizzy drinks, alcohol, citrus juices, tomato-based foods, spicy meals and coffee are all established triggers for acid reflux in general. On Wegovy, where gastric emptying is already slower, these triggers tend to have a stronger effect than usual. Cutting them back during the adjustment period is rarely a permanent sacrifice.

Over-the-counter antacids can provide short-term relief and are generally safe alongside Wegovy, but it is worth letting your prescriber know if you are using them regularly, so they have the full picture. For people with more persistent symptoms, a short course of a proton pump inhibitor may be considered, that is a clinical decision, not something to self-prescribe for long.

You can explore how Wegovy and the heart interact across different body systems, or read more about the ways in which Wegovy helps the heart according to the cardiovascular evidence behind semaglutide, and find out what is known about how Wegovy affects heart rate in people using it for weight management.

When heartburn on Wegovy warrants prompt attention

Most reflux on Wegovy is straightforward and responds to the adjustments described above. A smaller number of cases need a clinician's input sooner rather than later.

Contact your GP or prescriber promptly if you develop severe stomach pain that radiates to your back, with or without vomiting, this pattern can indicate acute pancreatitis, which the MHRA identified as a known but infrequent serious side effect of GLP-1 medicines in a Drug Safety Update issued in January 2026. Pancreatitis requires urgent medical assessment and is distinct from ordinary heartburn, though it can be confused with it.

Other symptoms that warrant prompt attention: difficulty or pain on swallowing, vomiting blood or material that looks like coffee grounds, unexplained weight loss alongside the reflux (rather than the expected appetite-related loss), or chest pain that feels different from the typical heartburn sensation. These are not common side effects of Wegovy, they are symptoms that need ruling out regardless of what medicine you are taking.

Ordinary heartburn that persists beyond four to six weeks at a stable dose, rather than easing, is also worth flagging. It does not necessarily mean you need to stop Wegovy, but your prescriber needs to know so they can assess whether an additional medication or a modified approach makes sense.

If you have an established history of gastro-oesophageal reflux disease (GORD) or Barrett's oesophagus, mention it at the consultation stage, it is relevant clinical information that shapes how your prescriber approaches the titration. You can read more about Wegovy and how it is used for weight management or check the frequently asked questions for broader clinical queries, and if you are curious about the wider picture, our pages covering Wegovy and heart health and the effects Wegovy has on the heart are worth a read alongside this one. Our clinical team reviews every consultation personally. When you are ready, start your free consultation and a prescriber will assess your full picture, including any digestive history that affects how the treatment should be approached.